Tech Company Financing Transactions
Syapse Funding Round
Syapse secured a $30 million Series D financing round on 11/15/2017. Investors included Amgen Ventures, Ascension Ventures and GE Ventures.
Transaction Overview
Company Name
Announced On
11/15/2017
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors
Proceeds Purpose
Syapse's series D financing will enable more healthcare providers to use precision medicine to improve care for their cancer patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
303 2nd St. North Tower 500
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Built on a powerful cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ken Tarkoff
Chief Financial Officer
Fletcher Payne
Chief Marketing Officer
Thomas Brown
Chief Technical Officer
Tony Loeser
President
Jonathan Hirsch
VP - Human Resources
Michelle Kemling
VP - Product Management
Vinod Subramanian
Browse more venture capital transactions:
Prev: 11/15/2017: LeanTaaS venture capital transaction
Next: 11/15/2017: GoFormz venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs